
Another day, another insider sale
LifeStance Health’s CTO, Vukasin Paunovich, sold 42,067 shares for roughly $541,402. That’s the kind of move that makes investors glance up from their coffee and ask: is this routine portfolio housekeeping, or does someone inside the building think the stock has gotten a little too cozy with reality?
Why you should care
Insider selling can mean a bunch of different things. Sometimes it’s a planned sale, tax bill, or a diversification move — basically, the financial version of cleaning out your closet. But when executives sell meaningful chunks, traders often read between the lines and wonder whether management sees fewer easy gains ahead.
For LifeStance holders, the headline won’t change the business overnight. Still, insider activity is one of those little breadcrumbs investors follow when trying to figure out whether the people closest to the numbers are leaning bullish or quietly heading for the exit.
Big picture: one insider sale is not a thesis killer, but it’s definitely worth keeping on your radar.